$698.74
Currently 34 wall-street analysts regularly analyze the financials of Regeneron Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals, Inc. (REGN) have a share price target of $926.66. This median of share price forecast represents a 32.62% upside from the latest price of $698.74 as on 06.03.25.
As per the chart shown above, analysts believe that the Regeneron Pharmaceuticals, Inc. (REGN) share price will touch around $926.66 in next 12-months.
Below is a chart showing the percentage difference between Regeneron Pharmaceuticals, Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -21.75%
Based on 34 analysts tracking and researching Regeneron Pharmaceuticals, Inc. (REGN) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 18 | 17 | 17 |
Outperform | 8 | 9 | 9 |
Hold | 5 | 7 | 7 |
Underperform | 0 | 0 | 0 |
Sell | 1 | 1 | 1 |